Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
about
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor targetTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesA primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitroMurine models to evaluate novel and conventional therapeutic strategies for cancerCytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cellsPreclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and RecommendationsBioengineering Models for Breast Cancer ResearchCurrent State of Animal (Mouse) Modeling in Melanoma ResearchColorectal cancer models for novel drug discoveryTumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsPeptide Hydrogels - Versatile Matrices for 3D Cell Culture in Cancer MedicineIn vitro human cell line models to predict clinical response to anticancer drugsCombination therapeutics in complex diseasesSpecies differences in tumour responses to cancer chemotherapyMouse models of colorectal cancer as preclinical modelsAssessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastasesEstablishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasReporting of preclinical tumor-graft cancer therapeutic studies.The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinomaA meta-analysis of threats to valid clinical inference in preclinical research of sunitinibMicroenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro modelEngineering cancer microenvironments for in vitro 3-D tumor models.Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Molecular characterization of putative chordoma cell linesTherapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancerCryopreservation of human colorectal carcinomas prior to xenografting.Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts.Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancerToward 3D biomimetic models to understand the behavior of glioblastoma multiforme cellsSystematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeArray comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.Experimental models of hepatocellular carcinomaGeneration of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceEstablishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivoUse of a chemically induced-colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassayThe nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.
P2860
Q24608574-AE2A47F6-034B-4F32-A7BE-840FFF1934D7Q24630783-E441F03C-E399-437A-8367-63F87A9E25A8Q24647698-21434F62-6C85-4194-8CEB-2B077FEFC45AQ24673595-74C1A505-3853-42C0-BD45-BF5FA12003D2Q24793862-47BAFD20-DE02-4A9A-B8BF-C6A5B7FFE891Q26767798-6326A64C-B6E6-4F60-B37F-92745BA7AF72Q26770495-E0A70D2E-FEFA-4127-86AF-16E79E3E763FQ26781652-2AA7D1EB-498E-4B7C-AB9C-F23AC24F71DBQ26795724-4E57D54B-D147-4085-B340-92B00BF23669Q26801410-1AA1FB37-5537-4178-A539-763F34C30F0AQ26860533-68FE9DE9-7EDE-40D3-A182-07B22951DB94Q27000665-10CA9C38-9121-46B4-BA4A-E9E941360235Q28076891-43141C81-98EB-4518-8F38-80CDB2163ED2Q28080727-7B5CCB4C-ED63-4DF6-8381-FB5F1B69459EQ28081871-916570B7-3563-4480-A483-E261C0E8B415Q28478248-50DED029-7535-4A2B-99B7-261DA6D5306AQ28484668-593DCA20-3DDD-45A0-9FA5-B45C7ACB6D86Q28485035-8C52D600-8F8D-424E-BCDD-520DB682EC26Q28538702-F07633A4-845D-410F-9F3F-BC08C1FAFF89Q28606538-0E5258E2-E0C6-4CFC-AD9A-6ED920A0C5B1Q28822135-7138BD5B-E6EF-432D-80CF-F463A162D3E5Q30358020-33158E80-863A-4E8E-9C42-C01F6923EA55Q30423597-8ABBCD68-4A7C-439C-82C9-2137F26A28D0Q33274040-DBC2523D-F0BC-4BB3-879C-40CE3CC803EFQ33326515-3F4C5984-9523-4671-BA81-E6383105E76CQ33628095-3FC5E852-13C6-4435-9AE6-F7A999E1DC96Q33680928-C6F6F25C-1D6E-49E1-805B-11B16F2D57A8Q33706073-F5DAC856-4161-48AD-8D38-E71D68F56042Q34001641-D649B2F9-B887-475A-9C58-2AC3B968A44FQ34025911-F3562FDB-07A0-4133-A862-8BFA6E3131A2Q34031153-164EDCA9-9E90-4F6C-8DE5-9BF3BDE61C4AQ34056295-D0824F1E-8BC0-47BB-A56B-0E98406E035CQ34059518-37B8B0CA-45B2-4193-B77F-58AF2B1BA95DQ34110523-D57A9271-DD9F-405E-B04F-A3B21480F26AQ34186642-BB13D74C-822E-42B6-B3D9-8F62CF0146F1Q34345987-6111675A-84D4-4FD4-B7A7-D9D9ED9A8AD3Q34372342-03643775-2D4E-4100-AE27-15263DE73CA8Q34402163-B7985940-D228-4B99-8D87-CFEA8A1FFA89Q34432024-3A16F5C3-17E3-427E-BF79-47E32F449C79Q34552077-981BF794-1CF0-4698-8B34-232B7F309452
P2860
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical predictive value of t ...... aft preclinical cancer models.
@ast
Clinical predictive value of t ...... aft preclinical cancer models.
@en
Clinical predictive value of t ...... aft preclinical cancer models.
@nl
type
label
Clinical predictive value of t ...... aft preclinical cancer models.
@ast
Clinical predictive value of t ...... aft preclinical cancer models.
@en
Clinical predictive value of t ...... aft preclinical cancer models.
@nl
prefLabel
Clinical predictive value of t ...... aft preclinical cancer models.
@ast
Clinical predictive value of t ...... aft preclinical cancer models.
@en
Clinical predictive value of t ...... aft preclinical cancer models.
@nl
P2093
P1476
Clinical predictive value of t ...... aft preclinical cancer models.
@en
P2093
Joseph L Pater
Lesley Seymour
Theodora Voskoglou-Nomikos
P304
P407
P577
2003-09-01T00:00:00Z